Torgersen Helge, Schmidt Markus
Institute of Technology Assessment, Austrian Academy of Sciences, Strohgasse 45, 1030 Vienna, Austria.
Futures. 2013 Apr;48(100):44-54. doi: 10.1016/j.futures.2013.02.002.
A stimulated early public debate is frequently advocated when introducing an emerging technology like synthetic biology (SB). To debate a still quite abstract technology, participants functionally need a frame that determines which arguments are legitimate and which issues are relevant. Often, such frames are based on previous debates over other novel technologies. Three technologies currently provide frames for discussing SB: (green) biotechnology, nanotechnology and information technology. In the biotechnology debate, risk has long been emphasised over economic benefits. More recently, nanotechnology has been referred to mostly in terms of benefits, while risks tended to be an issue for scientific discourses. This has frequently been related to the many outreach activities around nanotechnology. Information technology, finally, has retained the image of being 'cool' and useful on a personal level. The technology itself is taken for granted and only the consequences of particular applications have been up for discussion. Upstream engagement exercises in SB will have to consider the comparator chosen more diligently, because it might influence the debate on SB 'out there' in the long run.
在引入合成生物学(SB)等新兴技术时,人们经常提倡开展早期的公开辩论。要对一项仍然相当抽象的技术进行辩论,参与者实际上需要一个框架来确定哪些论点是合理的,哪些问题是相关的。通常,这样的框架基于之前对其他新技术的辩论。目前有三种技术为讨论合成生物学提供了框架:(绿色)生物技术、纳米技术和信息技术。在生物技术辩论中,长期以来人们更强调风险而非经济效益。最近,纳米技术大多是从效益方面被提及,而风险往往是科学讨论的问题。这常常与围绕纳米技术开展的众多推广活动有关。最后,信息技术在个人层面上一直保持着“酷炫”且有用的形象。这项技术本身被视为理所当然,只有特定应用的后果才会被讨论。合成生物学中的上游参与活动必须更谨慎地考虑所选择的比较对象,因为从长远来看,它可能会影响“外部”关于合成生物学的辩论。